56Z-10981-94459
3 vaccinations
4 coded responses
31 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 908 / CA
- Registered
- 2021-04-22
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-04-21
Dose 1 — Pfizer-BioNTech
-
2021-04-22
Registered in v-safe
-
2021-04-22
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Headache — Feeling: Good · Site: Pain · Chills, HeadacheFree text: Very mild chills and very mild headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 1MedDRA: Feeling hot, Headache — Feeling: Good · HeadacheFree text: Mild headache and slight warm feeling possible fever but faded quicklyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
-
2021-05-13
Dose 2 — Pfizer-BioNTech
- 2021-05-13
-
2021-05-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-15
- 2021-05-17
- 2021-05-22
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-06-17
- 2021-06-24
- 2021-08-14
- 2021-11-11
-
2021-12-09
Dose 3 — Pfizer-BioNTech
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-12-11
- 2021-12-12
- 2021-12-14
- 2021-12-18
- 2021-12-23
- 2022-01-08
- 2022-01-13
- 2022-01-22
- 2022-03-10
-
2022-06-09
Survey response — 6 months, dose 3MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pregnancy and COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Survey response — 12 months, dose 3MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny nose cough sore throatMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-21 | Pfizer-BioNTech | |
| 2 | 2021-05-13 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Very mild chills and very mild headache
Systemic reaction (other): Mild headache and slight warm feeling possible fever but faded quickly
Release 12 — 6 months, dose 3
Symptoms: Pregnancy and COVID
Release 12 — 12 months, dose 3
Symptoms: Runny nose cough sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release